Role of SLc11a1 Gen in Warm Ischemia-Reperfusion Injury

SLc11a1 Gen 在热缺血再灌注损伤中的作用

基本信息

  • 批准号:
    6618611
  • 负责人:
  • 金额:
    $ 10.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): While improvements in surgical techniques and pharmacological interventions have improved the outcome of liver resections, hemorrhagic shock, and organ transplantation, injury, rejection and eventual organ failure due to Ischemia-reperfusion (I/R) injury continue to be common place in the clinical setting. Accordingly, the development of novel treatment modalities to prevent or minimize I/R injury would be of tremendous benefit. Substantial evidence exist to support the notion that Kupffer cells (KC) are responsible for the early-phase of I/R injury, and sets the stage for the more severe polymorphonuclear leukocyte (PMN)-mediated late-phase injury. However, mechanisms by which KC and PMNs mediate their respective phases of I/R injury are not fully understood. This is reflected in the lack of success with conventional modes of therapeutic intervention both at the experimental and clinical levels. We have identified a gene, Slc11a1, which is induced during I/R injury, and mediates the production of pro-and anti-inflammatory cytokines. Consistent with this is the reduced levels of plasma TNF-alpha observed in Slc11a1-/- mice during the early phase of liver I/R injury. Slc11a1 proposed function of the regulating iron homeostasis in KC and PMNs, and its level of expression may ultimately determine if the liver is protected from I/R injury by modulating the degree of injury during both the early- and late-phases of I/R injury. To test this hypothesis we propose three aims: (1) We will determine if disruption of the Slc11a1 gene protects the mouse liver from I/R injury. To investigate this, we will look at both the early- and late-phases of I/R injury in the mouse liver model, in vivo. Standard biochemical and histological techniques will be employed to evaluate blood transaminases and H&E liver sections, in conjunction with molecular techniques to monitor the protein and mRNA levels of Slc11a1 and pro-and anti-inflammatory cytokines. (2) We will determine if disruption of the Slc11a1 gene blunts the activation/priming of KC and infiltrating PMNs during I/R injury. Slc11a1 mediates the activation of KC and PMNs. Therefore, we will isolate these cells from livers subjected to I/R, and use standard biochemical and molecular techniques to evaluate their degree of activation/priming by looking at spontaneous superoxide anion and NO production, and NF-kappaB activation. (3) We will determine the mechanism(s) by which the Slc11a1 gene elicits activation of KC and PMNs. If disruption Slc11a1 protects the liver from I/R injury by modulating mediation of iron homeostasis, then deferoxamine pretreatment of Slc11a1+/+ mice before I/R injury should protect the liver from I/R mediated injury, as observed for Slc11a1-/- mice. Furthermore, pretreatment with Fe2SO4 should reverse the protection observed in Slc11a11-/- mice. As in Aim #1, we will assess liver injury with use of standard biochemical and histological techniques. These studies will identify molecular mechanisms by which Slc11a1 modulates liver I/R injury, and will provide a novel target for therapeutic intervention in I/R-mediated organ injury.
描述(由申请人提供): 虽然手术技术和药物干预的改进改善了肝切除术、出血性休克和器官移植的结果,但由于缺血-再灌注(I/R)损伤导致的损伤、排斥和最终器官衰竭仍然是临床环境中常见的问题。因此,开发新的治疗方式来预防或最小化I/R损伤将具有巨大的益处。大量证据支持枯否细胞(KC)负责I/R损伤的早期阶段,并为更严重的多形核白细胞(PMN)介导的晚期损伤奠定基础。然而,KC和PMNs介导各自I/R损伤阶段的机制尚未完全清楚。这反映在传统的治疗干预模式在实验和临床层面都缺乏成功。我们已经确定了一个基因,Slc 11 a1,这是诱导在I/R损伤,并介导生产的促炎和抗炎细胞因子。与此一致的是,在肝I/R损伤的早期阶段,在Slc 11 a1-/-小鼠中观察到血浆TNF-α水平降低。Slc 11 a1可能具有调节KC和PMN铁稳态的功能,其表达水平可能最终决定肝脏是否通过调节I/R损伤早期和晚期的损伤程度而免受I/R损伤。为了验证这一假设,我们提出了三个目标:(1)我们将确定Slc 11 a1基因的破坏是否保护小鼠肝脏免受I/R损伤。为了研究这一点,我们将在小鼠肝脏模型中观察I/R损伤的早期和晚期。将采用标准生化和组织学技术评估血液转氨酶和H&E肝脏切片,结合分子技术监测Slc 11 a1的蛋白质和mRNA水平以及促炎和抗炎细胞因子。(2)我们将确定Slc 11 a1基因的破坏是否减弱了I/R损伤期间KC和浸润性PMN的激活/引发。Slc 11 a1介导KC和PMN的活化。因此,我们将从I/R的肝脏中分离这些细胞,并使用标准的生物化学和分子技术通过观察自发的超氧阴离子和NO产生以及NF-κ B活化来评估其活化/引发程度。(3)我们将确定Slc 11 a1基因引发KC和PMN激活的机制。如果破坏Slc 11 a1通过调节铁稳态的介导来保护肝脏免受I/R损伤,那么在I/R损伤之前对Slc 11 a1 +/+小鼠进行去铁胺预处理应该保护肝脏免受I/R介导的损伤,如对Slc 11 a1-/-小鼠所观察到的那样。此外,用Fe 2SO 4预处理应该会逆转在Slc 11 a11-/-小鼠中观察到的保护作用。与目标1相同,我们将使用标准生化和组织学技术评估肝损伤。这些研究将确定Slc 11 a1调节肝脏I/R损伤的分子机制,并将为I/R介导的器官损伤的治疗干预提供新的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAMUEL WYLLIE其他文献

SAMUEL WYLLIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAMUEL WYLLIE', 18)}}的其他基金

Role of SLc11a1 Gen in Warm Ischemia-Reperfusion Injury
SLc11a1 Gen 在热缺血再灌注损伤中的作用
  • 批准号:
    6747380
  • 财政年份:
    2003
  • 资助金额:
    $ 10.76万
  • 项目类别:
Role of SLc11a1 Gen in Warm Ischemia-Reperfusion Injury
SLc11a1 Gen 在热缺血再灌注损伤中的作用
  • 批准号:
    6899235
  • 财政年份:
    2003
  • 资助金额:
    $ 10.76万
  • 项目类别:
Role of SLc11a1 Gen in Warm Ischemia-Reperfusion Injury
SLc11a1 Gen 在热缺血再灌注损伤中的作用
  • 批准号:
    7272439
  • 财政年份:
    2003
  • 资助金额:
    $ 10.76万
  • 项目类别:
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
少数族裔博士前奖学金计划
  • 批准号:
    2384485
  • 财政年份:
    1996
  • 资助金额:
    $ 10.76万
  • 项目类别:
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
少数族裔博士前奖学金计划
  • 批准号:
    2114081
  • 财政年份:
    1996
  • 资助金额:
    $ 10.76万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CD30 targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice
CD30靶向治疗诱导炎症细胞因子刺激的滑膜成纤维细胞凋亡并改善胶原抗体诱导的小鼠关节炎
  • 批准号:
    20K09433
  • 财政年份:
    2020
  • 资助金额:
    $ 10.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of asbestos on apoptosis, proliferation and cytokine production of regulatory T cells
石棉对调节性 T 细胞凋亡、增殖和细胞因子产生的影响
  • 批准号:
    25860471
  • 财政年份:
    2013
  • 资助金额:
    $ 10.76万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.
雄激素调节的细胞因子网络控制前列腺细胞凋亡。
  • 批准号:
    9115277
  • 财政年份:
    2011
  • 资助金额:
    $ 10.76万
  • 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
  • 批准号:
    8549718
  • 财政年份:
    2011
  • 资助金额:
    $ 10.76万
  • 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
  • 批准号:
    8187541
  • 财政年份:
    2011
  • 资助金额:
    $ 10.76万
  • 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
  • 批准号:
    8735868
  • 财政年份:
    2011
  • 资助金额:
    $ 10.76万
  • 项目类别:
Molecular Control of Cytokine Withdrawal-Induced Apoptosis in Human Lymphocytes
细胞因子撤退诱导的人淋巴细胞凋亡的分子控制
  • 批准号:
    7291157
  • 财政年份:
    2007
  • 资助金额:
    $ 10.76万
  • 项目类别:
Role of TNF receptor-related factor 6(TRAF6) in the apoptosis induction and cytokine receptor signaling
TNF受体相关因子6(TRAF6)在细胞凋亡诱导和细胞因子受体信号转导中的作用
  • 批准号:
    19590075
  • 财政年份:
    2007
  • 资助金额:
    $ 10.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of malignant tumor by inclusive examination of apoptosis-related molecule and cytokine in children
细胞凋亡相关分子及细胞因子综合检查分析儿童恶性肿瘤
  • 批准号:
    19790728
  • 财政年份:
    2007
  • 资助金额:
    $ 10.76万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Cytokine, apoptosis, and homing receptor in acute exanthematous viral infe
急性发疹病毒感染中的细胞因子、细胞凋亡和归巢受体
  • 批准号:
    12670834
  • 财政年份:
    2000
  • 资助金额:
    $ 10.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了